Intellia Therapeutics
NTLA
#5607
Rank
โ‚น129.43 B
Marketcap
โ‚น922.18
Share price
1.65%
Change (1 day)
22.63%
Change (1 year)

EPS for Intellia Therapeutics (NTLA)

EPS in 2026 (TTM): -โ‚น307.90

According to Intellia Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น314.25. In 2025 the company made an earnings per share (EPS) of -โ‚น358.21 an increase over its 2024 EPS that were of -โ‚น491.02.

EPS history for Intellia Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น307.90-14.04%
2025-โ‚น358.21-27.05%
2024-โ‚น491.02-2.96%
2023-โ‚น505.98-12.46%
2022-โ‚น578.0064.36%
2021-โ‚น351.6656.67%
2020-โ‚น224.46
2018-โ‚น186.126.99%
2017-โ‚น173.9671.4%
2016-โ‚น101.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น126.26-59.82%๐Ÿ‡บ๐Ÿ‡ธ USA